IN2012DN00359A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00359A
IN2012DN00359A IN359DEN2012A IN2012DN00359A IN 2012DN00359 A IN2012DN00359 A IN 2012DN00359A IN 359DEN2012 A IN359DEN2012 A IN 359DEN2012A IN 2012DN00359 A IN2012DN00359 A IN 2012DN00359A
Authority
IN
India
Prior art keywords
agent
omeprazole
antioxidant
directed
oral administration
Prior art date
Application number
Other languages
English (en)
Inventor
Juvonen Erik
Massimo Micolucci Louis
Original Assignee
Vetegen Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43465734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00359(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vetegen Llc filed Critical Vetegen Llc
Publication of IN2012DN00359A publication Critical patent/IN2012DN00359A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN359DEN2012 2009-07-20 2010-07-20 IN2012DN00359A (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22689009P 2009-07-20 2009-07-20
PCT/US2010/042508 WO2011011351A2 (en) 2009-07-20 2010-07-20 A stable pharmaceutical omeprazole formulation for oral administration

Publications (1)

Publication Number Publication Date
IN2012DN00359A true IN2012DN00359A (hu) 2015-05-22

Family

ID=43465734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN359DEN2012 IN2012DN00359A (hu) 2009-07-20 2010-07-20

Country Status (11)

Country Link
US (1) US8530500B2 (hu)
EP (1) EP2456439A4 (hu)
JP (1) JP2012533633A (hu)
AU (1) AU2010276404A1 (hu)
CA (1) CA2768024A1 (hu)
CL (1) CL2012000169A1 (hu)
CO (1) CO6491061A2 (hu)
EC (1) ECSP12011618A (hu)
IN (1) IN2012DN00359A (hu)
PE (1) PE20120781A1 (hu)
WO (1) WO2011011351A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA026456B1 (ru) * 2011-12-16 2017-04-28 Атопикс Терапьютикс Лимитед Фармацевтическая композиция на основе антагониста crth2 и ингибитора протонного насоса для лечения эозинофильного эзофагита
GB201306720D0 (en) 2013-04-12 2013-05-29 Special Products Ltd Formulation
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
GB2561355A (en) * 2017-04-10 2018-10-17 Eaststone Ltd Pharmaceutical composition and a method for manufacturing the same
CN107397719A (zh) * 2017-08-16 2017-11-28 洛阳市兽药厂 一种畜禽用奥美拉唑可溶性粉剂及其制备工艺
GB2585628A (en) * 2019-05-08 2021-01-20 Alkaloid Ad Pharmaceutical formulation
GB2616663A (en) * 2022-03-18 2023-09-20 Alkaloid Ad Skopje Pharmaceutical formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
EP1156806B1 (en) * 1999-02-23 2004-04-07 Merck & Co., Inc. Pharmaceutical composition containing proton pump inhibitors
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
US20050239845A1 (en) * 2004-04-16 2005-10-27 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract

Also Published As

Publication number Publication date
WO2011011351A2 (en) 2011-01-27
WO2011011351A3 (en) 2011-05-19
CA2768024A1 (en) 2011-01-27
US8530500B2 (en) 2013-09-10
EP2456439A2 (en) 2012-05-30
PE20120781A1 (es) 2012-06-27
JP2012533633A (ja) 2012-12-27
US20110015233A1 (en) 2011-01-20
EP2456439A4 (en) 2012-12-26
AU2010276404A1 (en) 2012-02-02
CO6491061A2 (es) 2012-07-31
ECSP12011618A (es) 2012-04-30
CL2012000169A1 (es) 2012-08-31

Similar Documents

Publication Publication Date Title
IN2012DN00359A (hu)
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
MX369121B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
WO2009115178A3 (de) Gingival-wafer
MX336741B (es) Composiciones farmaceuticas de moduladores de c-met.
EA201290984A1 (ru) Гелеобразные фармацевтические композиции, препятствующие злоупотреблению
MX2009011165A (es) Formulaciones farmaceuticas que contienen derivados del acido lipoico.
ZA200800239B (en) Mucosal or enteral administration of biobogically active macromolecules
HK1158969A1 (en) Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
TN2012000392A1 (en) Oral formulations and lipophilic salts of methylnaltrexone
WO2012174158A3 (en) Administration of benzodiazepine
EP2258350A3 (en) Taste masked dosage form containing roflumilast
WO2012009723A8 (en) C-met modulator pharmaceutical compositions
WO2011086093A3 (en) Pharmaceutical compositions for oral administration of insulin peptides
WO2009149056A3 (en) Combinations of niacin and an oxicam
WO2010009140A3 (en) Methods, systems and devices for administration of chlorine dioxide
MX2010005198A (es) Composiciones liquidas que comprenden valsartan.
WO2008046865A3 (en) Long-term feed - elderly
WO2014137797A3 (en) Stable glucokinase activator compositions
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
WO2011076840A3 (en) Aerosol formulation for copd
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
WO2009048940A3 (en) Diacerein pharmaceutical formulations
WO2011017488A3 (en) Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity